These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3042926)

  • 1. Reduced saphenous vein prostacyclin production in the absence of endothelial detachment: a marker of functional damage by high potassium cardioplegic solutions to saphenous vein bypass grafts.
    De Caterina R; Cruz-Bracho MR; Alonso DR; Subramanian VA; Weksler BB
    J Nucl Med Allied Sci; 1988; 32(1):17-26. PubMed ID: 3042926
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional endothelial damage by high-potassium cardioplegic solutions to saphenous vein bypass grafts.
    De Caterina R; Weksler BB; Alonso DR; Cruz-Bracho MR; Subramanian VA
    Surgery; 1985 Sep; 98(3):465-71. PubMed ID: 3898452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro effects of cardioplegic solutions on human saphenous vein endothelium--a scanning electron microscopy study.
    Macchiarelli G; Chiavarelli R; Macchiarelli AG; Chiavarelli M; Nigri G; Fabi F; Del Basso P; Motta PM; Marino B
    Thorac Cardiovasc Surg; 1994 Oct; 42(5):264-70. PubMed ID: 7863487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damage to arterial and venous endothelial cells in bypass grafts induced by several solutions used in bypass surgery.
    Schaeffer U; Tanner B; Strohschneider T; Stadtmüller A; Hannekum A
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):168-71. PubMed ID: 9323817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostacyclin production in internal mammary ano radial arteries and saphenous veins of diabetic and non diabetic subjects].
    Guivernau M; Berr M
    Rev Med Chil; 2008 Jul; 136(7):823-30. PubMed ID: 18949156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of crystalloid potassium cardioplegic solution on arterialized canine vein grafts. Assessment of chronic prostacyclin production and histopathologic alterations.
    Hoover EL; Pett SB; Eldor A; Alonso D; Subramanian VA; Weksler B; Gay WA
    Circulation; 1981 Aug; 64(2 Pt 2):II96-100. PubMed ID: 7018737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and ultrastructural integrity of the saphenous vein conduit during coronary artery bypass grafting. Preliminary results of the effect of papaverine.
    Roberts AJ; Hay DA; Mehta JL; Mehta P; Roy L; Faro RS; Knauf DG; Alexander JA
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):39-48. PubMed ID: 6376960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity.
    Dashwood MR; Savage K; Tsui JC; Dooley A; Shaw SG; Fernández Alfonso MS; Bodin L; Souza DS
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):334-40. PubMed ID: 19619776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cardioplegic solutions and their components on human saphenous vein contractility.
    Chiavarelli M; Fabi F; Stati T; Chiavarelli R; del Basso P
    Ann Thorac Surg; 1992 Mar; 53(3):455-9. PubMed ID: 1540064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of stretch or distention on phenylephrine-induced constriction of human coronary artery bypass grafts.
    Wendling WW; Krasner LJ; Cooper SC; Chen D; Harakal C; Addonizio VP; Brister NW; Carlsson C
    J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):717-22. PubMed ID: 11748519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
    Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary endothelium and cardioplegic solutions.
    Mattila S; Harjula A; Mattila I; Myllärniemi H; Härkönen M
    Ann Chir Gynaecol; 1987; 76(1):46-50. PubMed ID: 3496035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution.
    Sanchez AM; Wooldridge TA; Boerboom LE; Olinger GN; Almassi GH; Rusch NJ
    J Thorac Cardiovasc Surg; 1994 Jun; 107(6):1445-53. PubMed ID: 8196386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PGI2-like activity of the internal mammary artery and the saphenous vein used in coronary bypass surgery].
    Homolay P; Bordánné Jenes E; Takács EI; Péterffy A
    Orv Hetil; 1993 Apr; 134(14):731-5. PubMed ID: 8464626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin.
    Angelini GD; Breckenridge IM; Psaila JV; Williams HM; Henderson AH; Newby AC
    Cardiovasc Res; 1987 Jan; 21(1):28-33. PubMed ID: 3311362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surgical preparative technique for coronary bypass grafts of human saphenous vein which preserves medial and endothelial functional integrity.
    Angelini GD; Breckenridge IM; Williams HM; Newby AC
    J Thorac Cardiovasc Surg; 1987 Sep; 94(3):393-8. PubMed ID: 3306164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in intracellular concentration of amino acids in human saphenous vein during preparation for coronary artery bypass grafting.
    Suleiman MS; Wallace D; Birkett S; Angelini GD
    Cardiovasc Res; 1995 Nov; 30(5):747-54. PubMed ID: 8595622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the incubation medium on the endothelium of autologous vein grafts: damage scoring by scanning electron microscopy.
    Konerding MA; Knocks M; Zerkowski HR
    Scanning Microsc; 1996; 10(3):841-8; discussion 848-9. PubMed ID: 9813644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioplegic storage solution: Is it the guardian of saphenous vein graft endothelium?
    Papakonstantinou NA; Sykaras AG; Vourlakou C; Goudevenos J; Papadopoulos G; Apostolakis E
    J Card Surg; 2020 May; 35(5):996-1003. PubMed ID: 32207185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein.
    Broeders MA; Doevendans PA; Maessen JG; van Gorsel E; Egbrink MG; Daemen MJ; Tangelder GJ; Reneman RS; van der Zee R
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):305-9. PubMed ID: 11479503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.